The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib

The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib was developed by the experts of the Russian Association of Endocrinologists and the Russian Society of Clinical Oncology. The consensus contains recommendation o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Natalya V. Mazurina, Elena V. Artamonova, Maria F. Beloyartseva, Ekaterina I. Volkova, Inna P. Ganshina, Ekaterina A. Troshina, Sergey A. Tjulandin, Viacheslav A. Chubenko
Formato: article
Lenguaje:RU
Publicado: IP Habib O.N. 2021
Materias:
Acceso en línea:https://doaj.org/article/95b6d9b471d74d51ad5bf1e4d91f076f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:95b6d9b471d74d51ad5bf1e4d91f076f
record_format dspace
spelling oai:doaj.org-article:95b6d9b471d74d51ad5bf1e4d91f076f2021-11-30T17:03:34ZThe consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib1815-14341815-144210.26442/18151434.2020.4.200566https://doaj.org/article/95b6d9b471d74d51ad5bf1e4d91f076f2021-02-01T00:00:00Zhttps://modernonco.orscience.ru/1815-1434/article/viewFile/61146/44235https://doaj.org/toc/1815-1434https://doaj.org/toc/1815-1442The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib was developed by the experts of the Russian Association of Endocrinologists and the Russian Society of Clinical Oncology. The consensus contains recommendation on risk assessment, prophylaxis and correction of hyperglycemia regarding the baseline metabolic status of the patients.Natalya V. MazurinaElena V. ArtamonovaMaria F. BeloyartsevaEkaterina I. VolkovaInna P. GanshinaEkaterina A. TroshinaSergey A. TjulandinViacheslav A. ChubenkoIP Habib O.N.articleconsensushyperglycemiaalpelisibbreast cancerpik3ca mutationNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282RUСовременная онкология, Vol 22, Iss 4, Pp 56-59 (2021)
institution DOAJ
collection DOAJ
language RU
topic consensus
hyperglycemia
alpelisib
breast cancer
pik3ca mutation
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle consensus
hyperglycemia
alpelisib
breast cancer
pik3ca mutation
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Natalya V. Mazurina
Elena V. Artamonova
Maria F. Beloyartseva
Ekaterina I. Volkova
Inna P. Ganshina
Ekaterina A. Troshina
Sergey A. Tjulandin
Viacheslav A. Chubenko
The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
description The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib was developed by the experts of the Russian Association of Endocrinologists and the Russian Society of Clinical Oncology. The consensus contains recommendation on risk assessment, prophylaxis and correction of hyperglycemia regarding the baseline metabolic status of the patients.
format article
author Natalya V. Mazurina
Elena V. Artamonova
Maria F. Beloyartseva
Ekaterina I. Volkova
Inna P. Ganshina
Ekaterina A. Troshina
Sergey A. Tjulandin
Viacheslav A. Chubenko
author_facet Natalya V. Mazurina
Elena V. Artamonova
Maria F. Beloyartseva
Ekaterina I. Volkova
Inna P. Ganshina
Ekaterina A. Troshina
Sergey A. Tjulandin
Viacheslav A. Chubenko
author_sort Natalya V. Mazurina
title The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
title_short The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
title_full The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
title_fullStr The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
title_full_unstemmed The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
title_sort consensus on the prevention and correction of hyperglycemia in patients with hr+ her2- metastatic breast cancer treated with alpelisib
publisher IP Habib O.N.
publishDate 2021
url https://doaj.org/article/95b6d9b471d74d51ad5bf1e4d91f076f
work_keys_str_mv AT natalyavmazurina theconsensusonthepreventionandcorrectionofhyperglycemiainpatientswithhrher2metastaticbreastcancertreatedwithalpelisib
AT elenavartamonova theconsensusonthepreventionandcorrectionofhyperglycemiainpatientswithhrher2metastaticbreastcancertreatedwithalpelisib
AT mariafbeloyartseva theconsensusonthepreventionandcorrectionofhyperglycemiainpatientswithhrher2metastaticbreastcancertreatedwithalpelisib
AT ekaterinaivolkova theconsensusonthepreventionandcorrectionofhyperglycemiainpatientswithhrher2metastaticbreastcancertreatedwithalpelisib
AT innapganshina theconsensusonthepreventionandcorrectionofhyperglycemiainpatientswithhrher2metastaticbreastcancertreatedwithalpelisib
AT ekaterinaatroshina theconsensusonthepreventionandcorrectionofhyperglycemiainpatientswithhrher2metastaticbreastcancertreatedwithalpelisib
AT sergeyatjulandin theconsensusonthepreventionandcorrectionofhyperglycemiainpatientswithhrher2metastaticbreastcancertreatedwithalpelisib
AT viacheslavachubenko theconsensusonthepreventionandcorrectionofhyperglycemiainpatientswithhrher2metastaticbreastcancertreatedwithalpelisib
AT natalyavmazurina consensusonthepreventionandcorrectionofhyperglycemiainpatientswithhrher2metastaticbreastcancertreatedwithalpelisib
AT elenavartamonova consensusonthepreventionandcorrectionofhyperglycemiainpatientswithhrher2metastaticbreastcancertreatedwithalpelisib
AT mariafbeloyartseva consensusonthepreventionandcorrectionofhyperglycemiainpatientswithhrher2metastaticbreastcancertreatedwithalpelisib
AT ekaterinaivolkova consensusonthepreventionandcorrectionofhyperglycemiainpatientswithhrher2metastaticbreastcancertreatedwithalpelisib
AT innapganshina consensusonthepreventionandcorrectionofhyperglycemiainpatientswithhrher2metastaticbreastcancertreatedwithalpelisib
AT ekaterinaatroshina consensusonthepreventionandcorrectionofhyperglycemiainpatientswithhrher2metastaticbreastcancertreatedwithalpelisib
AT sergeyatjulandin consensusonthepreventionandcorrectionofhyperglycemiainpatientswithhrher2metastaticbreastcancertreatedwithalpelisib
AT viacheslavachubenko consensusonthepreventionandcorrectionofhyperglycemiainpatientswithhrher2metastaticbreastcancertreatedwithalpelisib
_version_ 1718406394848215040